Transgenomic Reports Second Quarter 2015 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/1/2026

1. INTC
2. AMZN
3. RDDT
4. PINS
5. COIN
6. FSLR
7. SYK
8. SBUX
9. SNDK
10. MA

Go back to Transgenomic Reports Second Quarter 2015 Financial Results

Transgenomic (TBIO) Tops Q2 EPS by 11c

August 13, 2015 4:36 PM EDT

Transgenomic (NASDAQ: TBIO) reported Q2 EPS of ($0.30), $0.11 better than the analyst estimate of ($0.41). Revenue for the quarter came in at $7 million versus the consensus estimate of $7.1 million.

Transgenomic made solid progress in the second quarter in our ongoing transformation into an advanced technology company primarily focused on commercializing the many applications of our Multiplexed ICE COLD-PCR (MX-ICP) technology, said Paul Kinnon, President and Chief Executive Officer. Importantly, we reported good increases in sales in our strategically important businesses, with overall net sales up four percent year over year, and up 11% after adjusting for our... More